Université Catholique de Louvain
Transcriptome study of individual cells isolated from synovial biopsies: can it help in the therapeutic management of early rheumatoid arthritis ?
Projet soutenu de Patrick Durez : Early diagnosis and therapeutic management of Rheumatoid arthritis (RA) are crucial. Early RA is treated with methotrexate (MTX) and after 3 months, approximately 45% of patients are in remission or low disease activity. There is no biomarker that can predict the level of response to MTX. The objective is to identify a transcriptomic signature associated with clinical response to MTX. We will analyze by scRNAseq synovial cells from 20 patients at baseline and at 16 weeks for non-responders.
Ont aussi bénéficié d'un soutien
KU Leuven (RA Clinical Research Group, Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven)
What is the optimal tapering strategy for rituximab in patients with Rheumatoid Arthritis: comparison of interval prolongation with disease activity guided dose reduction
Projet soutenu de Patrick Verschueren : Rituximab is an effective drug, but it is expensive and might be accompanied by an increased infection risk. Therefore, lowering the dose …
Lire la suite
UZ Leuven/ KU Leuven
Clinical field tests as predictors of cardiorespiratory fitness and cardiometabolic risk in Psoriatic Arthritis.
Projet soutenu de Barbara Neerinckx : This project will study the potential of low cost, objective and highly generalisable clinical field tests, six minute walk and hand grip st…
Lire la suite